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Introduction
Tight junctions form the physiological and structural paracellular
barrier and demarcate the apical and basolateral domains of
polarized epithelial cells. Although a very large number of structural
and signaling proteins have been identified at this specialized cell-
cell contact (Gonzalez-Mariscal et al., 2003; Schneeberger and
Lynch, 2004; Guillemot et al., 2008), the exact composition of
individual tight junctions shows some tissue-specific variability.
For example, among the integral membrane proteins associated
with the tight junction different members of the claudin family of
proteins are variably expressed in different tight junctions (Furuse
and Tsukita, 2006; Van Itallie and Anderson, 2006). By contrast,
the transmembrane protein occludin is an invariant component,
found in all epithelial and endothelial tight junctions.
Occludin has been the subject of considerable interest since its
discovery by Tsukita and co-workers in 1993 (Furuse et al., 1993).
Overexpression studies demonstrated that it could influence the
function of tight junction barriers (Balda et al., 2000), but the
subsequent demonstration that the occludin knockout mouse had
physiologically and structurally normal tight junctions (Saitou et
al., 2000; Schulzke et al., 2005) argued against a critical role for
occludin as a barrier-forming protein. However, despite having
apparently normal barrier properties, the null phenotype includes
numerous abnormalities in many organs.
Occludin is a member of a larger protein family of Marvel
(MAL-related proteins for vesicle trafficking and membrane link)-
domain-containing proteins (Sanchez-Pulido et al., 2002). Most of
these proteins, for example synaptophysins, synaptogyrins and
MAL (myelin and lymphocyte proteins) family members, are
involved in vesicle trafficking, although their exact functions are
unclear. Of note, many studies have demonstrated that occludin
endocytosis is a common feature of tight junction injury and is
closely associated with physiological barrier disruption (for a
review, see Yu and Turner, 2008). Along with a putative role in
trafficking, a second characteristic shared by many Marvel domain
family members is an association with lipid rafts, cholesterol and/or
caveolin. Occludin itself was shown to be a component of a
detergent-resistant membrane microdomain (Nusrat et al., 2000;
Lambert et al., 2005; Lynch et al., 2007) and several studies have
implicated the importance of a cholesterol-rich membrane domain
in tight junction function. For example, removal of cholesterol
from wild-type MDCK cells results in decreased transepithelial
electrical resistance (TER), but has no effect on TER in occludin-
depleted MDCK cells (Yu et al., 2005). In addition, occludin has
also been demonstrated in co-immunoprecipitation experiments to
interact with the cholesterol-binding protein caveolin-1 (Nusrat et
al., 2000; Lynch et al., 2007). There is significant evidence that
occludin functions within a lipid microdomain, although it remains
unclear whether occludin plays an active or passive role in
organizing this microdomain.
Caveolin-1 is a small, ubiquitously expressed integral membrane
protein that is involved in both clathrin-independent endocytosis
(Pelkmans and Helenius, 2002; Nichols, 2003) and in formation of
cholesterol-rich membrane microdomains. These microdomains
can act as signaling platforms through their interactions with G-
protein subunits, receptor and non-receptor protein kinases and
small GTPases, among other proteins (Head and Insel, 2007).
Several studies have implicated the importance of caveolin-1-
dependent occludin endocytosis in tight junction disruption. For
example, in vivo administration of TNF (Marchiando et al., 2010)
results in occludin endocytosis and increased epithelial
permeability; neither occludin endocytosis nor increased
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Summary
The function of occludin remains elusive. Proposed roles include maintenance of tight junction barriers, signaling and junction
remodeling. To investigate a potential role in mediating cytokine-induced changes in barrier properties, we measured barrier responses
to interferon- plus TNF in control, occludin-overexpressing and occludin knockdown MDCK II monolayers. MDCK cells show a
complex response to cytokines characterized by a simultaneous increase in the transepithelial electrical resistance and a decrease in
the barrier for large solutes. We observed that overexpression of occludin increased and occludin knockdown decreased sensitivity to
cytokines as assessed by both these parameters. It is known that caveolin-1 interacts with occludin and is implicated in several models
of cytokine-dependent barrier disruption; we found that occludin knockdown altered the subcellular distribution of caveolin-1 and that
partitioning of caveolin into detergent-insoluble lipid rafts was influenced by changing occludin levels. Knockdown of caveolin
decreased the cytokine-induced flux increase, whereas the increase in the electrical barrier was unaltered; the effect of double
knockdown of occludin and caveolin was similar to that of occludin single knockdown, consistent with the possibility that they
function in the same pathway. These results demonstrate that occludin is required for cells to transduce cytokine-mediated signals that
either increase the electrical barrier or decrease the large solute barrier, possibly by coordinating the functions of caveolin-1.











permeability occur after cytokine administration to caveolin-1
knockout mice.
We hypothesized that although occludin might be dispensable
for baseline barrier function, it might be required to mediate some
signaling events that normally result in barrier remodeling and that
caveolin-1 might be involved in this interaction. To test this
hypothesis, we focused on stimuli that result in caveolin-dependent
occludin endocytosis, in particular treatment of MDCK cells with
TNF plus IFN and with Latrunculin A (Shen and Turner, 2005).
We found that barrier changes were increased in cells
overexpressing occludin and decreased in occludin knockout cells.
In addition, we found that depletion of occludin resulted in
alterations in caveolin-1 distribution and partitioning in detergent-
insoluble rafts. Together these results suggest an active requirement
for occludin in mediating barrier responses to cytokines, perhaps
through an effect on caveolin-1 or other lipid microdomain
signaling processes at the junction.
Results
Overexpression of occludin increases baseline TER but
not baseline flux
Occludin expression was increased about fourfold compared with
control levels by removal of doxycycline in MDCK II Tet-Off cell
lines (Fig. 1A), but there were no changes in the levels of claudin-
2 or caveolin-1. Immunofluorescence analysis of uninduced and
induced cell lines (Fig. 1B) showed that induction of occludin had
no effect on ZO-1 staining, but it did result in increased
immunofluorescence signal both at cell contacts and in intracellular
compartments. Comparison of TER of uninduced and induced cell
lines (Fig. 1C) demonstrates a greater than twofold increase in
TER in induced cells; this increase is larger than has been reported
elsewhere (McCarthy et al., 1996; Balda et al., 1996), but this
difference is probably due to different cell handling procedures, as
described in the Materials and Methods section. We further
characterized the permeability of non-charged solutes using a
graded series of PEG oligomers (Van Itallie et al., 2008) (Fig. 1D).
This method has the advantage of separately revealing the
permeability of the small claudin-based pores (less than 4 Å radius)
from the leak pathway for larger solutes (larger than 4 Å radius).
Although others have previously reported increased mannitol flux
after occludin overexpression (McCarthy et al., 1996; Balda et al.,
1996), we did not see flux differences between uninduced and
induced cell lines. This is unlikely to represent a difference in
sensitivity between the measurement techniques, since the PEG
method can detect small changes in flux, but might be due to
differences in occludin expression levels, clonal differences or
culture conditions. Under our conditions we consistently found
that increasing occludin levels increases TER but not the flux for
larger solutes or the size discrimination of the junction.
Overexpression of occludin increases physiologic
responses to treatment with proinflammatory cytokines or
Latrunculin A
Co-treatment of monolayers of MDCK cells with IFN and TNF
is known to increase both TER and paracellular flux (Patrick et al.,
2006). To test the role of occludin in the response to cytokines, we
compared the TER of MDCK cells uninduced or induced to express
human occludin after 24 hours of cytokine treatment. Exposure to
100 ng/ml IFN and 30 ng/ml TNF resulted in a significant
increase in TER (Fig. 2A), as previously described (Patrick et al.,
2006). Occludin-overexpressing cells had higher basal TER, and
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the magnitude of their response to cytokine treatment was larger
than in the uninduced cells (2.2-fold compared with 1.7-fold).
Paracellular flux was similarly enhanced by occludin
overexpression as measured by permeability of fluorescein-labeled
3-kDa dextran (Fig. 2B). This tracer size is larger than the claudin
pores and reveals permeability of the leak pathway. Dextran flux
was increased less than twofold after cytokine treatment of
uninduced cells, but more than threefold in cells overexpressing
occludin. Both occludin and ZO-1 localization was still continuous
at the tight junction after cytokine treatment in both uninduced or
induced cells. However, there appeared to be more intracellular
occludin staining in the occludin-overexpressing cells after cytokine
treatment compared with untreated induced cells (supplementary
material Fig. S1).
Shen and Turner (Shen and Turner, 2005) demonstrated that
depolymerization of F-actin with Latrunculin A results in a
concentration- and time-dependent drop in TER in MDCK II cells.
This disruption is dependent on occludin internalization. To
determine if overexpression of occludin might increase the
sensitivity to Latrunculin A, we compared the time course of the
drop in TER after administration of 0.5 M Latrunculin A to
uninduced and induced MDCK cells (Fig. 2C). Occludin
overexpression resulted in a faster drop in TER after Latrunculin
A administration compared with the response in uninduced MDCK
cells. Thus, elevating occludin makes the barrier more responsive
to both cytokines and an actin-depolymerizing drug.
Fig. 1. Characterization of occludin-overexpressing MDCK cell lines.
(A) Immunoblots of two cell lines that were uninduced (U) or induced (I) to
express human occludin (Ocln) show an approximate fourfold increase in
occludin levels, but no change in claudin-2 (Cln2) or caveolin-1 (Cav-1)
expression. (B) Immunofluorescence imaging of ZO-1 and occludin in
uninduced and induced cells reveals no change in the distribution or intensity
of ZO-1 after occludin induction, but that the occludin signal in induced cells
is brighter and more is present in intracellular compartments compared with
uninduced cells. Scale bar: 8 m. (C) Occludin induction (grey bar) increases
TER by approximately twofold when compared with uninduced cells (white
bar), from 47.6±1.3 cm2 to 113.3±17.6 cm2, *P<0.002.
(D) Measurement of the size-dependence of paracellular permeability assessed
with PEG oligomers reveals no change in flux for uncharged molecules in the
size range of 3-7 Å after occludin induction (closed circles). All experiments











Knockout of occludin in MDCK II cells does not alter the
baseline barrier properties as measured by electrical
resistance or size-dependence of permeability for non-
charged solutes
Since overexpression of occludin increased the magnitude of the
barrier responses to cytokines, we next asked whether knockdown
(KD) of occludin (Ocln) had the opposite effect. We first confirmed
the previously published behavior of occludin KD cells and
compared the results with tricellulin knockdown cells generated in
our laboratory. Consistent with previously published results (Yu et
al., 2005) we found that KD of Ocln in MDCK cell monolayers
does not alter the levels (Fig. 3A) or localization (Fig. 1B) of
several other tight junction and adherens junction proteins. We
found a similar lack of effect of tricellulin KD on the levels of
other tight junction proteins (Fig. 3A, right) and their distribution
(Fig. 3B, right panel). All clonal knockdown lines expressed less
than 5% of the control occludin or tricellulin levels and some faint
staining in the Ocln KD cell lines is visible in Fig. 3 and in other
figures. Unlike a previous report (Ikenouchi et al., 2008), we did
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not find that occludin knockdown altered tricellulin distribution.
This might reflect variation in the degree of occludin knockdown
or in antibody sensitivity. We normally see a very low level of
bicellular staining with our tricellulin antibody and this is not
significantly altered in the occludin-depleted cells. In addition, we
did not observe a change in occludin distribution in tricellulin-
depleted cells as was reported in occludin-depleted Eph4 cells
(Ikenouchi et al., 2005).
Also, consistent with results published by Yu and coworkers (Yu
et al., 2005), we observed no significant change in TER after
depletion of occludin (Fig. 3C), or in the permeability for uncharged
solutes (Fig. 3D) as determined by the PEG profiling assay. This
is consistent with published findings that occludin depletion does
not alter barrier permeability for non-charged solutes, which are
larger than the claudin pores as assessed with single tracers (Saitou
et al., 1998; Yu et al., 2005; Schulzke et al., 2005). Furthermore,
we saw no significant alteration in barrier properties in tricellulin-
depleted MDCK II cells, as measured by either TER (Fig. 3C) or
by permeability for PEG oligomers (Fig. 3D). This finding differs
Fig. 2. Occludin overexpression increases cytokine responses. (A) Cytokine
treatment results in a 1.7-fold increase in TER (from 49±1 to 83±3 cm2) in
uninduced MDCK cells and in a greater than 2-fold increase in TER (from
100±13 to 222±36 scm2) in cells overexpressing occludin.
(B) Measurement of paracellular flux with fluorescein-labeled 3-kDa dextran
after cytokine treatment of MDCK cells uninduced and induced to express
human occludin shows a similar increase in response. Dextran flux is similar
in both uninduced and induced untreated cell lines; flux increases 60% after
cytokine treatment in uninduced cells and more than threefold in cells
overexpressing occludin. *P<0.05 compared with uninduced controls;
**P<0.02 when compared with cytokine-treated uninduced cells. All
experiments were performed with two separate clonal cell lines, two or more
times. (C) Time course of reduction of TER in cells uninduced and induced to
overexpress occludin in response to Latrunculin A (added at 0 minutes). The
electrical barrier is significantly more sensitive to disruption when occludin is
overexpressed.
Fig. 3. Characterization of occludin and tricellulin knockdown (KD)
MDCK cell lines reveals no changes in expression and localization of other
proteins and barrier function. (A) Immunoblots of occludin (Ocln),
tricellulin (Tric), claudin-2 (Cldn2), E-cadherin (eCad), ZO-1, ZO-2 and actin
in MDCK II Tet-Off parental cells and representative Ocln KD and Tric KD
cell lines. Ocln and Tric KDs expressed less than 5% of the respective
endogenous protein levels; there were no consistent changes in the expression
levels of the other tight and adherens junction proteins tested. Actin was used
as a loading control. (B) Co-immunolocalization of ZO-1, Ocln and Tric in
control and KD cell lines shows no consistent changes in cell shape or tight
junction protein localization. Scale bars: 10 m; the merged images show ZO-
1 (red) and tricellulin (yellow). (C,D) Measurement of TER (C) and size-
dependence of paracellular permeability assessed with PEG oligomers (D)
revealed no significant change in barrier characteristics in control MDCK,
Ocln KD and Tric KD monolayers; at least three separate clonal KD cell lines











from a previous study performed in Eph4 cells (Ikenouchi et al.,
2005) but might represent a cell-specific difference.
Knockdown of occludin attenuates barrier disruption
induced by either pro-inflammatory cytokines or
Latrunculin A
To determine if the effects of IFN and TNF on paracellular
permeability requires occludin, we treated parental and Ocln KD
cells with these cytokines as described above and measured TER
and flux of fluorescent 3-kDa dextran. After 24 hours of combined
treatment with IFN and TNF, MDCK II parental cells showed
nearly a twofold increase in TER, whereas cytokine treatment of
Ocln KD cells resulted in a TER increase of only 20% (Fig. 4A).
Ocln KD cells similarly showed less responsiveness to cytokine
treatment than did control cells when assessed by changes in
dextran flux; in MDCK parental cells flux was significantly
increased, whereas treatment of Ocln KD cells failed to increase
dextran flux above that observed in untreated Ocln KD cells (Fig.
4B). Again, ZO-1 localization was unaltered after cytokine
treatment in either control or Ocln KD cells (supplementary material
Fig. S2). Thus, responses of the barrier to cytokines are directly
related to occludin levels whether occludin is increased or decreased
from control levels.
To determine if the observed drop in electrical resistance after
Latrunculin A treatment also required occludin, we compared the
time course of TER after treatment with Latrunculin A in MDCK
parental and Ocln KD cells. As previously reported, MDCK II
control cells showed a concentration- and time-dependent decrease
in TER (time course for 0.5 M shown in Fig. 4C), although the
drop in TER we observed was slower and less extensive than that
reported previously (Shen and Turner, 2005). Depletion of occludin,
but not tricellulin (not shown), resulted in a significant decrease in
the rate of TER drop in response to Latrunculin A compared to its
effect on the parental cell line. A similar reduced sensitivity to
Latrunculin A in Ocln KD cells was evident at two other Latrunculin
A doses tested (0.25 and 1 M; not shown). In spite of the relative
difference in sensitivity to Latrunculin A seen in parental MDCK
and Ocln KD cell lines, disruption of the actin filament pattern was
similar in both lines after treatment (Fig. 4D).
Inducible expression of occludin in KD cell lines restores
sensitivity to Latrunculin A
To verify that the decreased sensitivity to Latrunculin A was due
to depletion of occludin and not to variation among clonal cell
lines, we tested the effect of Latrunculin A on Ocln KD cell lines
that were engineered to inducibly express a human occludin
transgene. Induction of occludin by removal of doxycycline resulted
in occludin levels that were similar to those in control cells (Fig.
4E). When Ocln KD cells uninduced or induced to re-express
occludin were treated with 0.5 M Latrunculin A, there was a
significant increase in the sensitivity of the induced cells compared
with their uninduced controls (Fig. 4F). Latrunculin A sensitivity
was restored to levels observed in the parental lines (compare with
Fig. 4C).
Depletion of occludin alters localization of caveolin-1
A recent study by Turner and co-workers (Marchiando et al., 2010)
using caveolin-1 knockout mice demonstrated that caveolin-1 is
required for TNF regulation of tight junctions in vivo. In addition,
previous studies demonstrated that caveolin-1 is widely distributed
throughout the cell on the apical and basolateral cell membranes
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and in intracellular vesicles but that a fraction colocalizes and is
physically associated with occludin. For example, occludin co-
immunoprecipitates with caveolin (Nusrat et al., 2000; Lynch et
al., 2007), the two proteins colocalize at the tight junction at the
ultrastructural level as revealed by immuno-gold techniques (Nusrat
et al., 2000), and when endocytosis is stimulated they can be found
in the same vesicles (Shen and Turner, 2005; Stamatovic et al.,
Fig. 4. Ocln KD cell lines are less sensitive to proinflammatory cytokines.
(A) Treatment of parental MDCK II Tet-Off cells resulted in a 1.9-fold
increase in TER (from 56±2 to 107±6 cm2), while treatment of occludin
KD cells increased TER only 1.2-fold above untreated levels (from 52±2 to
62±6 cm2). (B) Treatment of MDCK control and Ocln KD monolayers
with TNF and IFN resulted in a significant increase in flux of fluorescent
3-kDa dextran in control cells but not in Ocln KD cells. (C) Administration of
Latrunculin A (0.5 M) to monolayers of control MDCK and two separate
Ocln KD cell lines resulted in time-dependent decreases in TER in all cell
lines; however, the decrease in Ocln KD cells is significantly less than in
MDCK controls at all time points longer than 30 minutes. (D) Rhodamine-
phalloidin labeling of F-actin (right panels) at the cellular level of maximal
ZO-1 staining intensity (left panels) in untreated MDCK (top row) and Ocln
KD cells (second row) revealed similar actin localization; 60 minutes of
0.5 M Latrunculin A (Lat A) treatment of MDCK (third row) and Ocln KD
cells (bottom row) did not alter continuous ZO-1 staining in either cell line but
resulted in similar changes in actin localization. (E) Immunoblot analysis of
MDCK control cells, Ocln KD cells and Ocln KD cells transfected with a Tet-
responsive vector containing Vsv-g-tagged human Ocln either uninduced (U)
or induced (I) to express Ocln-Vsv-g; blots were probed for Ocln, using an
antibody that recognizes both canine and human occludin, Vsv-g and caveolin-
1; the results shown are representative of two similar clones; occludin
induction levels are 1.5-fold control values. (F) Re-expression of an Ocln
transgene restores Latrunculin A sensitivity. Treatment of Ocln KD cells (two
independent clonal cell lines) uninduced (U) and induced (I) to express human
Ocln with 0.5 M latrunculin A demonstrates induction of Ocln is associated
with increased sensitivity to latrunculin A and thus results in a larger decrease











2009). These observations led us to investigate whether depleting
occludin might alter the distribution of caveolin-1. To compare the
distribution of caveolin in control and Ocln KD cells, we co-plated
both cell types on Transwell filters. Confocal maximum density
projection images of caveolin-1, occludin and ZO-1 in confluent
mixed cell populations (Fig. 5) revealed normal ZO-1 localization
(Fig. 5, top left) in both parental and Ocln KD cells. Occludin
immunofluorescent analysis of the mixed cell population (Fig. 5,
top right) revealed parental (Ocln) and Ocln KD cell patches; the
boundaries between these patches are outlined with a dotted line.
The dotted line overlaid on the caveolin-1 signal (Fig. 5, Cav-1,
lower right) revealed that caveolin in the Ocln KD cells appeared
primarily associated with the lateral cell membranes, with reduced
intracellular staining relative to the adjacent occludin-positive cells
(Fig. 5, lower right). This immunofluorescence suggested that Ocln
KD cells might have lower levels of caveolin; however, in spite of
the apparent difference in caveolin distribution, caveolin protein
levels are indistinguishable in control and knockdown cell lines as
determined by immunoblotting (Fig. 4E).
Depletion or overexpression of occludin alters the fraction
of caveolin-1 associated with detergent-insoluble lipid
rafts
As noted above, some caveolin and occludin are normally
associated with detergent-insoluble lipid rafts. Although only a
fraction of the total cell caveolin would be expected to interact
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with occludin, we examined whether depletion or overexpression
of occludin led to a detectable alteration of the fraction of caveolin
that is associated with the Triton-X-100-insoluble membrane
fraction. Sucrose gradient fractionation of Ocln KD cells compared
with control MDCK cells (Fig. 6A, top panel) revealed a small but
consistent shift of caveolin from low density (centered around
1.12 g/ml) raft-associated fractions to higher density (centered
around 1.19 g/ml) non-raft fractions (quantified from several
replicate gradients in Fig. 6B, top panels); this shift is reversed in
the MDCK II cell induced (Fig. 6A,B, bottom panels) to express
human occludin.
Knockdown of caveolin-1 does not alter the cytokine-
induced change in TER but does alter responsiveness of
the pathway for large solutes
Because we showed that occludin can regulate the subcellular
distribution of caveolin-1 and caveolin-1 controls several signaling
pathways, we asked whether KD of cavolin-1 would also alter
Fig. 5. Maximum density confocal projection of occludin and caveolin-1
immunofluorescence in mixed populations of MDCK control and Ocln
KD cells reveals global differences in caveolin distribution. MDCK
parental and Ocln KD cells were co-cultured on Transwell filters, fixed and
stained for Ocln, ZO-1 and caveolin and imaged using confocal microscopy.
All sections through cells were collapsed to reveal the overall distribution of
caveolin; boundaries of parental and KD are delineated with white dashed
lines. ZO-1 immunofluorescence is identical in control and KD cells (yellow,
top right). Ocln immunofluorescence (top right panel, red) identifies control
and KD cells. Caveolin (bottom left panel, green) staining is brighter in control
cells than in KD cells and more appears to be present in intracellular vesicles
and/or on the apical surface. The merged image (right panel, red Ocln red;
green caveolin) demonstrates brighter apical membrane and/or cytosolic
staining of caveolin in Ocln-positive cells and more obvious lateral membrane
staining in Ocln KD cells. Scale bar: 10 m.
Fig. 6. Partitioning of caveolin-1 with low-density lipid rafts is influenced
by the level of Ocln. (A) Immunoblot of representative sucrose density
gradient fractions from parental MDCK, Ocln KD (top panels) and MDCK
cells uninduced (U) and induced (I) to express the human Ocln transgene
(bottom panels). The density of each fraction is shown below the immunoblot.
(B) Quantification of replicate sucrose gradients reveals a shift in caveolin-1
from less to more dense fractions in Ocln KD cells compared with the MDCK
parental cell lines (compare top panels) and a shift in the opposite direction in
Ocln-overexpressing cells (bottom two panels); each gradient was repeated











responsiveness of the barrier to cytokines. Stable caveolin-1
knockdown cell lines were generated using both the MDCK Tet-
Off parental line to make a single KD and the Ocln KD cells to
make a double KD. Immunoblot comparison of parental cells,
caveolin-1 KD, Ocln KD and the double occludin-caveolin KDs
(Fig. 7A) demonstrate our cavolin-1 KDs still express 15-20% of
endogenous caveolin-1; this was in spite of testing many clonal
cell lines and the use of the same sequence previously reported to
result in expression levels of 5-10% of controls (Manninen et al.,
2005). Caveolin knockdown does not alter occludin levels and
there appeared to be small differences in claudin-2 levels, which
was not seen in other KD cell lines; -tubulin was used as a
loading control. Knockdown of caveolin-1 does not alter occludin
distribution (Fig. 7B); the localization of ZO-1 (7B, top left) and
occludin (7B, top right panel) is identical in a mixed population of
caveolin-1-expressing cells and caveolin-1 knockdown cells (Fig.
7B, lower right panel). Thus, caveolin-1 does not obviously regulate
occludin location but occludin influences caveolin-1 location.
The measurement of TER in parental and knockdown cells (Fig.
7C) reveals little difference in baseline TER among all cell lines,
but cytokine treatment of both parental MDCK cells and caveolin
KD cells results in a twofold increase in electrical resistance,
whereas the occludin and occludin–caveolin double KD cells show
only a 50% increase in resistance. Flux measurement in the same
2849Occludin and caveolin
cell lines shows little difference in baseline flux (Fig. 7D), but after
cytokine treatment, flux is significantly increased only in the
MDCK parental cells. Both occludin and caveolin KD decrease the
cytokine effect on tight junction barrier properties, and the double
knockdown is similar to the Ocln KD alone, suggesting caveolin
and occludin might function in the same pathway.
Occludin expression levels do not mediate alterations in
cytokines responses via differential changes in actin
localization
Co-treatment of MDCK II cells with IFN and TNF is known to
change F-actin localization (Patrick et al., 2006). To determine
whether the differential responses of parental MDCK and Ocln
KD cells to cytokines correlated with effects of Ocln KD on F-
actin distribution, we compared actin localization in both cell lines
before and after cytokine treatment. ZO-1 and F-actin localization
in control cells (Fig. 8, left panels) demonstrated that at the cellular
level of maximal ZO-1 staining intensity, F-actin appeared as a
thin ring and in a speckled apical location, perhaps associated with
microvilli in both parental and Ocln KD cells. After cytokine
treatment (Fig. 8, right panels), actin appeared condensed into a
brighter peri-junctional ring in both parental MDCK cells and in
Ocln KD cells. Immunofluorescent localization of myosin 2B was
also more distinct in the peri-junctional ring after cytokine
treatment, but this change was also indistinguishable between
parental and Ocln KD cells (supplementary material Fig. S2).
Thus, cytokines induce a similar peri-junctional focusing of F-
actin and myosin 2B independent of the occludin levels.
Discussion
There are two major new findings revealed by our studies. First,
we demonstrate that occludin plays an active required role in
cytokine-induced changes in tight junction barrier properties.
Overexpression of occludin increases whereas knockdown
decreases the response of MDCK cells to treatment with IFN plus
TNF. Second, knockdown of occludin plays an active role in the
cellular location of caveolin-1. Increasing occludin levels increases
association of caveolin-1 with detergent-resistant lipid rafts,
whereas occludin KD results in increased caveolin in non-raft
fractions. By contrast, KD of caveolin-1 does not alter occludin
distribution. Finally, similar to the occludin KD, knockdown of
caveolin is also associated with decreased responsiveness to
Fig. 7. Caveolin KD does not affect occludin levels or distribution but does
decrease the sensitivity of flux to cytokines. (A) Immunoblot analysis of KD
cells lines reveals partial KD of caveolin (80-85%) in both parental and
occludin KD lines. Claudin-2 levels appear slightly lower in the Cav-1 KD
line, but this was not seen in other KD lines; -tubulin was used as a loading
control. (B) Cav-1 KD does not alter occludin or ZO-1 immunolocalization;
this is best seen in a cell line with a mixed population of caveolin-expressing
and KD cells: ZO-1 (top left) and occludin (top right) are similar in all cells;
caveolin-1 (green, bottom left), and merged with occludin (red, bottom right).
Scale bar: 5 m. (C) Occludin but not caveolin KD decreases sensitivity to
cytokines as measured by TER, but (D) both occludin and caveolin KD
decrease sensitivity to cytokine treatment as measured by dextran flux; the
effect of the double occludin-caveolin KD was not different from that of
occludin KD alone. *P<0.02 compared with MDCK controls, **P<0.05
compared with cytokine-treated MDCK cells; each experiment was repeated
with at least two separate clonal cell lines.
Fig. 8. Occludin does not mediate changes in cytokine sensitivity via
differential changes in actin localization after cytokine treatment.
Fluorescent-actin localization in parental MDCK parental or occludin KD cells
at the level of ZO-1 (left four panels) reveals diffuse apical actin and a thin
peri-junctional actin ring. Treatment with IFN +TNF (right four panels)
caused no appreciable change in ZO-1 staining and a similar increased












cytokines, as measured by flux, but unlike occludin KD the increase
in TER still occurs. Together, these results demonstrate that occludin
is a required component in modulating the response of tight junction
barriers to cytokines and suggests that in part, it might act through
coordinating the functions of caveolin-1.
Cytokine treatment of intestinal cells results in increases in
paracellular flux and decreases in TER, and many studies have
described that disruption of tight junction barriers after exposure
to IFN and TNF results in displacement of tight junction proteins
and in particular, occludin (Capaldo and Nusrat, 2009). More
recently, it has been recognized that occludin endocytosis is a
common feature of responses not only to cytokine treatment but
also to exposure to bacteria, toxins (Yu and Turner, 2008) or some
viruses (Coyne et al., 2007; Liu et al., 2009). This endocytosis
coincides with and is required for barrier disruption, since blocking
endocytosis prevents cytokine- or toxin-induced increases in tight
junction permeability (Shen and Turner, 2005; Clayburgh et al.,
2005; Schwarz et al., 2007). In addition, there is recent in vivo
evidence for cytokine-induced occludin endocytosis, using
genetically modified mice expressing GFP-occludin (Marchiando
et al., 2010). However, there was no direct evidence that occludin
is required for the barrier loss in any of the above experiments. Our
results are the first to demonstrate that occludin is required for
changes in tight junction barrier responses to cytokines and that the
cytokine-induced changes in TER and flux are proportional to
occludin levels.
In contrast to intestinal cells, the barrier changes observed in
MDCK II cells differ in a noteworthy way. Although cytokines still
induce an increase in paracellular flux there is no loss of continuity
in tight junction staining for ZO-1 or occludin (this study) (Patrick
et al., 2006) and TER actually increases, indicating that the electrical
barrier is tightened after cytokine administration (Patrick et al.,
2006). This reveals that occludin is not only involved in disrupting
the barrier, presumably through endocytosis, but can also transduce
signals that tighten the electrical barrier. TER reveals the
instantaneous status of the paracellular space where small ions
move during an imposed electrical field. By contrast, flux studies
are typically performed over 1-3 hours and reveal dynamic
instabilities or transient breaks in the barrier, which allow larger
molecules to pass. Consequently, in MDCK cells occludin is
required for cytokines to disrupt the macromolecular barrier either
through endocytosis or altering the cytoskeleton as well as to
enhance the electrical barrier.
Occludin endocytosis has been reported to occur through a
variety of different mechanisms (Ivanov et al., 2005; Yu and Turner,
2008), although several recent studies have highlighted a role for
caveolin in this process (Shen and Turner, 2005; Coyne et al.,
2007; Marchiando et al., 2010). The most compelling of these is
the recent demonstration that caveolin-1 knockout mice show
decreased intestinal epithelial sensitivity to cytokines coincident
with decreased occludin endocytosis, consistent with a requirement
for caveolin-1 in this pathway (Marchiando et al., 2010). Consistent
with this result, we find in MDCK cells that caveolin-1 knockdown
also blunts the responses to cytokines. However, although
endocytosis is demonstrably an important component of the
response to cytokines (Foerg et al., 2007), another role for caveolin
is the organization of lipid-dependent signaling domains (Wei et
al., 1999).We speculate that extra occludin in MDCK cells could
be acting to enhance association with, and therefore the response
to, these signaling molecules; occludin KD could have the opposite
effect. This hypothesis is supported not only by the occludin-
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dependent change in caveolin localization demonstrated in this
study, but also by published studies demonstrating that occludin
can immunoprecipitate caveolin (Nusrat et al., 2000; Lynch et al.,
2007). Furthermore, caveolin but not occludin binds cholesterol,
yet the disruption to the function of tight junction barriers caused
by removal of cholesterol is dependent on the presence of occludin
(Yu et al., 2005). Cholesterol removal decreases caveolin levels
(Furuchi and Anderson, 1998) and thus lipid-raft-associated
signaling molecules; it is possible that altered signaling through
this complex can affect barrier function only when occludin is
present to recruit caveolin and lipid-raft molecules to the junction.
Candidate signaling molecules include src or G-protein subunits
(Head and Insel, 2007).
Endocytosis after cytokine treatment of epithelial cells is induced
in response to phosphorylation and activation of myosin II, either
by myosin light chain kinase (Zolotarevsky et al., 2002; Clayburgh
et al., 2005; Wang et al., 2005; Ma et al., 2005) or Rho-activated
kinase (Utech et al., 2005). Activation is associated with a
condensation of filamentous actin and myosin into the peri-
junctional ring (Clayburgh et al., 2005; Patrick et al., 2006). In our
studies we observed a similar level of actomyosin condensation in
response to cytokines in control and occludin KD cells. This
suggests myosin activity is not dependent on occludin and supports
the model in which myosin activation and cytoskeletal alterations
are upstream of occludin-dependent steps. This finding is supported
by published data (Shen and Turner, 2005) showing that inhibition
of occludin endocytosis by Latrunculin A blocks junction disruption
but not the actin reorganization induced by Latrunculin A.
Additionally, cytokine treatment of caveolin-1 KD animals
(Marchiando et al., 2010) fails to result in barrier disruption, in
spite of an observed increase in myosin light chain phosphorylation.
In summary, these data are the first demonstration the occludin
is required for cytokine-induced tight junction remodeling and
increasing occludin levels actually increase the responses. We also
show that occludin can affect the location and lipid raft partitioning
of caveolin-1. Since caveolin-1 is required for cytokine-induced
barrier changes in vivo (Marchiando et al., 2010), our results raise
the possibility that occludin enables caveolin function at the tight
junction where it participates in signals required for barrier
remodeling. Whether occludin is mainly involved in endocytosis-
dependent tight junction remodeling, as suggested by other studies,
or is also an organizer of signaling proteins during remodeling




All antibodies were purchased from Zymed/Invitrogen (Carlsbad, CA) unless
otherwise noted. Polyclonal guinea pig occludin antibodies were from HyCult
Biotechnology (Uden, Netherlands); the anti-ZO-1 rat monoclonal was a gift from
Bruce Stevenson (Stevenson et al., 1986). Polyclonal caveolin-1 antibody was from
Santa Cruz Biotechnology (Santa Cruz, CA), myosin 2B antibody was from Cell
Signaling Technology (Beverly, MA), and actin, -catenin and E-cadherin (DECMA)
antibodies and Rhodamine-phalloidin were purchased from Sigma Chemical Co. (St
Louis, MO).
Cell lines
Occludin-overexpressing MDCK II cell lines have been previously described (Medina
et al., 2000). Stable MDCK II cell lines depleted of occludin (Ocln KD) were
generously provided by Eveline Schneeberger, Massachusetts General Hospital,
Charlestown, MA (Yu et al., 2005); additional cell lines were generated in our
laboratory using the occludin knockdown vector in pSuper also provided by Eveline
Schneeberger. Rescue constructs for the Ocln KD cells were constructed using a full-
length human occludin cDNA with VSV-g tag on the C-terminus cloned into the
tetracycline-inducible pTRE vector (Medina et al., 2000); to prevent inhibition of












sequence was modified by the introduction of two silent mutations (Quikchange,
Stratagene, LaJolla, CA) in the sequence complimentary to the knockdown vector.
The oligonucleotide sequence used in this site-directed mutagenesis was: 5-
GACTATAGAGAAGAAAGTGAGGAATACATGGCTGCTGCTGATGA-3. Stable
cells were generated by co-transfection with pSVZeo (Invitrogen) using
Lipofectamine (Invitrogen) and selected using 1 mg/ml Zeocin (Invitrogen).
Tricellulin KD cells were similarly constructed in the MDCK II Tet-Off cell
background (Clontech, Mountain View, CA) using either pTER (generously provided
by M. van de Wetering and H. Clevers (Hubrecht Laboratory, Center for Biomedical
Genetics, Utrecht, The Netherlands) or pSuper vectors (Oligoengine, Seattle, WA);
the antisense oligonucleotides used were 5-GGTACAACCTGGTGGGCTA-3 and
5-CCCAGACTTCTACTCAAGT-3; vectors containing each sequence were
combined for transfection with Lipofectamine. pSVzeo was co-transfected with
pSuper knockdown vectors and stable cell lines were selected with 1 mg/ml Zeocin.
Stable cell lines depleted of caveolin-1 were generated using RVH-1-puro caveolin
knockdown vector generously provided by Kai Simons, Max Planck Institute of
Molecular Cell Biology and Genetics, Dresden, Germany (Manninen et al., 2005) or
pSuper containing the same knockdown sequence (5-GATGTGATTGCAGA -
ACCAG-3) cotransfected with pSVZeo and selected as above with 1 mg/ml Zeocin.
Immunoblot and immunofluorescence analyses
Immunoblot and immunofluorescence analyses were in general performed as
previously described (Van Itallie et al., 2009). Widefield images were acquired on a
Nikon E800 microscope using a 60 Plan Apo lens and an Orca ER cooled CCD
camera controlled with Metamorph imaging software package (version 6.0) Filter
sets and dye combinations were as previously described (Fanning et al., 2002).
Confocal images were acquired using a Zeiss LSM510 Meta using a 63 Pan Apo
lens. Confocal stacks and image projections were made using LSM image browser
3.2. Adobe Photoshop version 7.0 was used for contrast adjustment and montage
assembly.
Barrier assays: PEG and fluorescent-dextran flux and measurement of
transepithelial electrical resistance
Polyethylene glycol profiling to measure the size dependence of permeability of
non-charged solutes was described recently (Van Itallie et al., 2008); all measurements
were performed on triplicate filters and at least three different clonal cell lines.
Fluorescent dextran permeability was measured as previously described (Van Itallie
et al., 2009); these measurements were also performed on triplicate filters and at
least two different clonal cell lines. TER was determined using plate electrodes
positioned on either side of the monolayers placed in a Plexiglas cup attached to an
EVOM (Epithelial Volt Ohm Meter; WPI, Sarasota, FL); two Transwell filters were
left blank to determine the contribution of filter and medium in the absence of cells
to TER measurements. All measurements were performed on a minimum of triplicate
wells and the TER value of the blank filter was subtracted from the reading of the
filter with cells. Statistical analysis (ANOVA, Dunnett’s and t-tests) were performed
using GraphPad software (GraphPad Prism, San Diego, CA).
Cytokine treatment
Because maximal Ocln induction takes 4 days, Ocln-overexpressing cells were
plated in T25 flasks without or with 50 ng/ml doxycycline for 2 days and then plated
at confluent density without or with doxycycline (4105 cells/1.1 cm2 12-well
Transwell filters). MDCK, Ocln KD, Cav-1 KD and Ocln–Cav-1 KD cells were also
plated at confluent density (4105 cells/1.1 cm2 12-well Transwell filters) but in
medium without doxycycline; medium was changed after 24 hours. At 48 hours, the
medium was changed in half the wells and the in other half the fresh medium was
supplemented with 30 ng/ml TNF (Calbiochem, EMD Biosciences, Inc., La Jolla,
CA) and 100 ng/ml IFN (Biosource, Camarillo, CA). After incubation for 24 hours
with cytokines, cells were washed once and equilibrated with Hank’s balanced salt
solution for 20 minutes at 37°C. After 20 minutes, basolateral Hank’s was replaced
with 0.7 ml fresh Hank’s and apical Hank’s was replaced with 0.2 ml fresh Hank’s
containing 0.5-1.0 mg/ml 3-kDa fluorescent dextran (Molecular Probes, Invitrogen,
Carlsbad, CA). Flux assay was performed as above.
Latrunculin A treatment
Monolayers were plated at confluent density (4105 cells/1.1 cm2 12-well filter) and
medium was changed after 24 hours; Ocln-overexpressing and rescue cells were
plated as above. After 48 hours, the medium was changed to Hank’s balanced salt
solution supplemented with 15 mM HEPES, pH 7.4 (HBSS) as described by Shen
and Turner (Shen and Turner, 2005) and allowed to equilibrate for 60 minutes at
37°C. Basolateral medium was then changed to fresh HBSS containing differing
doses of latrunculin A (Invitrogen, Carlsbad, CA). TER was measured at the indicated
intervals following latrunculin A administration.
Detergent-resistant membrane preparation
Detergent-resistant membranes were prepared as described earlier (Van Itallie et al.,
2005) with some modifications. MDCK and Ocln KD cells were lysed in ice-cold
1% Triton X-100 in 25 mM Tris-HCl, pH 7.5, 5 mM EDTA (TNE). Cells were
solubilized by passing them through a 26 gauge needle 40 times and the resulting
homogenate was brought to 40% sucrose; 0.5 ml of this solution was placed in the
bottom of a 2.2 ml Ultraclear centrifuge tube, overlaid with 1 ml 38% sucrose in
TNE and finally with 0.7 ml 5% sucrose in TNE. Step gradients were centrifuged at
166,000 g for 3 hours in a Beckman TLS-55 rotor, 0.3 ml fractions were removed
and added to an equal volume of 4 SDS sample buffer. The resulting fractions
were analyzed by SDS-PAGE and immunoblot analysis as described above. The
density of fractions post centrifugation was assessed in duplicate blank gradients
using a Bausch and Lomb refractometer (Rochester, NY).
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